Form 4/A for UTHR UNITED THERAPEUTICS Corp
Accepted 2022-02-16 00:00:00 ET · period of report 2021-06-26 · accession 0001127602-22-005324 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2022-02-16 | 2021-06-26 | UTHR | Mesa Nilda | Dir | M - OptEx | $0.00 | +1,680 | 6,640 | +34% | $0 |
| DA | 2022-02-16 | 2021-06-26 | UTHR | Mesa Nilda | Dir | M - OptEx | $0.00 | -1,680 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-26 | M | A | 1,680 | $0.00 | 6,640 | D | — | — | (F1) This transaction was originally reported on a Form 4 filed on June 29, 2021, which incorrectly reported the amount beneficially owned following reported transaction as 1,680 due to a clerical error. |
| 2 | Derivative | Restricted Stock Units | 2021-06-26 | M | D | 1,680 | $0.00 | 0 | D | $0.00 · 2021-06-26 to — | 1,680 Common Stock | (F2) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. (F3) The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. (F4) The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. |